NCT01709292 2026-04-16
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
Clinical Trials
9 trialsNCT04948437 2026-04-13
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
National Taiwan University Hospital
Active not recruiting
NCT04624477 2025-11-28
Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer
University Health Network, Toronto
Active not recruiting
NCT03271892 2025-11-26
AS-PTC
University Health Network, Toronto
Active not recruiting
NCT04759911 2025-11-13
Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT04544111 2025-10-07
PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Active not recruiting
NCT07062211 2025-07-14
Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level
Superior University
Active not recruiting
NCT01398085 2024-05-08
IoN
University College, London
Phase 2/3 Active not recruiting
NCT06271044 2024-02-21
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
Helsinki University Central Hospital
Phase NA Active not recruiting